Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaveAu who wrote (8532)	1/28/2002 6:37:47 AM
From: Mark Bartlett	Read Replies (2) of 14101

Dave, <<Is DMX/Oxo now doing the same thing with WF10 ? It shouldn't take this long.>> They have to go back and review all of the patient charts (in many different centers) to ensure the trial protocols have been undertaken properly. In addition there was the delay due to Oxo running out of money -- so things were at a standstill during that period. Finally, their submission has to be flawless. The FDA is playing hardball these days -- recently they sent one submission back (for another company) because the text referenced a wrong chart. That delayed things for the company for months. Bottom line -- they have to be very careful, especially if they are considering fast-tracking the drug. MB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next